{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:59:24Z","timestamp":1771660764843,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,18]]},"DOI":"10.7759\/cureus.37768","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T15:25:25Z","timestamp":1681831525000},"source":"Crossref","is-referenced-by-count":2,"title":["Moyamoya Disease and Syndrome in Caucasian Patients"],"prefix":"10.7759","author":[{"given":"Nuno","family":"Neves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia","family":"Marto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra Bay\u00e3o","family":"Horta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.ra.2019-0059","article-title":"Influence of inflammatory disease on the pathophysiology of Moyamoya disease and quasi-Moyamoya disease","volume":"59","author":"Mikami T","year":"2019","unstructured":"Mikami T, Suzuki H, Komatsu K, Mikuni N. Influence of inflammatory disease on the pathophysiology of Moyamoya disease and quasi-Moyamoya disease. Neurol Med Chir (Tokyo). 2019, 59:361-70. 10.2176\/nmc.ra.2019-0059","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.ra.2014-0307","article-title":"Diagnosis of moyamoya disease: international standard and regional differences","volume":"55","author":"Fujimura M","year":"2015","unstructured":"Fujimura M, Tominaga T. Diagnosis of moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo). 2015, 55:189-93. 10.2176\/nmc.ra.2014-0307","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S42772","article-title":"Moyamoya disease and syndromes: from genetics to clinical management","volume":"8","author":"Guey S","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015, 8:49-68. 10.2147\/TACG.S42772","journal-title":"Appl Clin Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.050","article-title":"Local vasogenic edema without cerebral hyperperfusion after direct revascularization surgery for Moyamoya disease","volume":"24","author":"Sakata H","year":"2015","unstructured":"Sakata H, Fujimura M, Mugikura S, Sato K, Tominaga T. Local vasogenic edema without cerebral hyperperfusion after direct revascularization surgery for Moyamoya disease. J Stroke Cerebrovasc Dis. 2015, 24:e179-84. 10.1016\/j.jstrokecerebrovasdis.2015.03.050","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.002","article-title":"Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult Moyamoya disease","volume":"27","author":"Tashiro R","year":"2018","unstructured":"Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, Tominaga T. Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult Moyamoya disease. J Stroke Cerebrovasc Dis. 2018, 27:e172-6. 10.1016\/j.jstrokecerebrovasdis.2018.03.002","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2335\/scs.46.1","article-title":"Recommendations for the management of Moyamoya disease: a Statement from Research Committee on Spontaneous Occlusion of the Circle Willis (Moyamoya Disease)","volume":"46","author":"Tominaga T","year":"2018","unstructured":"Tominaga T, Suzuki N, Miyamoto S, et al.. Recommendations for the management of Moyamoya disease: a Statement from Research Committee on Spontaneous Occlusion of the Circle Willis (Moyamoya Disease). Surg Cereb Stroke. 2018, 46:1-24. 10.2335\/scs.46.1","journal-title":"Surg Cereb Stroke"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.010819","article-title":"Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial","volume":"47","author":"Takahashi JC","year":"2016","unstructured":"Takahashi JC, Funaki T, Houkin K, et al.. Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke. 2016, 47:37-43. 10.1161\/STROKEAHA.115.010819","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.004386","article-title":"Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial","volume":"45","author":"Miyamoto S","year":"2014","unstructured":"Miyamoto S, Yoshimoto T, Hashimoto N, et al.. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke. 2014, 45:1415-21. 10.1161\/STROKEAHA.113.004386","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3340\/jkns.2018.0101","article-title":"Hemorrhagic Moyamoya disease: a recent update","volume":"62","author":"Fujimura M","year":"2019","unstructured":"Fujimura M, Tominaga T. Hemorrhagic Moyamoya disease: a recent update. J Korean Neurosurg Soc. 2019, 62:136-43. 10.3340\/jkns.2018.0101","journal-title":"J Korean Neurosurg Soc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2014.16.2.65","article-title":"Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene","volume":"16","author":"Fujimura M","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T. Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke. 2014, 16:65-72. 10.5853\/jos.2014.16.2.65","journal-title":"J Stroke"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318249f71f","article-title":"Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease","volume":"78","author":"Miyatake S","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, et al.. Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012, 78:803-10. 10.1212\/WNL.0b013e318249f71f","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00701-014-2013-0","article-title":"Nationwide survey on quasi-moyamoya disease in Japan","volume":"156","author":"Hayashi K","year":"2014","unstructured":"Hayashi K, Horie N, Izumo T, Nagata I. Nationwide survey on quasi-moyamoya disease in Japan. Acta Neurochir (Wien). 2014, 156:935-40. 10.1007\/s00701-014-2013-0","journal-title":"Acta Neurochir (Wien)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.11.008","article-title":"Coexisting diseases of Moyamoya vasculopathy","volume":"23","author":"Wei YC","year":"2014","unstructured":"Wei YC, Liu CH, Chang TY, et al.. Coexisting diseases of Moyamoya vasculopathy. J Stroke Cerebrovasc Dis. 2014, 23:1344-50. 10.1016\/j.jstrokecerebrovasdis.2013.11.008","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12397","article-title":"Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery","volume":"21","author":"Tanaka M","year":"2014","unstructured":"Tanaka M, Sakaguchi M, Yagita Y, et al.. Thyroid antibodies are associated with stenotic lesions in the terminal portion of the internal carotid artery. Eur J Neurol. 2014, 21:867-73. 10.1111\/ene.12397","journal-title":"Eur J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.04.122","article-title":"Acute thyrotoxicosis of Graves disease associated with Moyamoya vasculopathy and stroke in Latin American women: a case series and review of the literature","volume":"92","author":"Shah NH","year":"2016","unstructured":"Shah NH, Khandelwal P, Gordon-Perue G, Shah AH, Barbarite E, Ortiz G, Forteza AM. Acute thyrotoxicosis of Graves disease associated with Moyamoya vasculopathy and stroke in Latin American women: a case series and review of the literature. World Neurosurg. 2016, 92:95-107. 10.1016\/j.wneu.2016.04.122","journal-title":"World Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9316-22","article-title":"Moyamoya Syndrome presenting with ischemic stroke caused by rapid worsening of vessel stenosis associated with triple-seropositive antiphospholipid syndrome","volume":"62","author":"Oura K","year":"2023","unstructured":"Oura K, Yamaguchi T, Suzuki T, Yamaguchi Oura M, Itabashi R, Maeda T. Moyamoya Syndrome presenting with ischemic stroke caused by rapid worsening of vessel stenosis associated with triple-seropositive antiphospholipid syndrome. Intern Med. 2023, 62:793-6. 10.2169\/internalmedicine.9316-22","journal-title":"Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314540761","article-title":"Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review","volume":"23","author":"Wang Z","year":"2014","unstructured":"Wang Z, Fu Z, Wang J, Cui H, Zhang Z, Zhang B. Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review. Lupus. 2014, 23:1204-6. 10.1177\/0961203314540761","journal-title":"Lupus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki J","year":"1969","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969, 20:288-99. 10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3171\/ped.2004.100.2.0142","article-title":"Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis","volume":"100","author":"Scott RM","year":"2004","unstructured":"Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004, 100:142-9. 10.3171\/ped.2004.100.2.0142","journal-title":"J Neurosurg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e318208f1da","article-title":"Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography","volume":"68","author":"Fujimura M","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery. 2011, 68:957-64; discussion 964-5. 10.1227\/NEU.0b013e318208f1da","journal-title":"Neurosurgery"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/150662-moyamoya-disease-and-syndrome-in-caucasian-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:38Z","timestamp":1707508778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/150662-moyamoya-disease-and-syndrome-in-caucasian-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.37768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}